Dyne Therapeutics (DYN) Operating Leases (2021 - 2026)
Dyne Therapeutics' Operating Leases came in at $14.51 million for Q2 2026, down 16.0% from $17.26 million a year earlier but up 1.6% from the prior quarter.
Powered by 
Analysis
Dyne Therapeutics (DYN) Operating Leases (2021 - 2026) Analysis & Trends
At the end of FY2025, Dyne Therapeutics' Operating Leases was $15.28 million, down 20.1% from FY2024.
- Operating Leases has declined in each of the last four years, with a four-year compound annual growth rate of -14.6% (FY2021 to FY2025).
- Going back by year, Operating Leases was $19.14 million in FY2024 (-15.7%), $22.7 million in FY2023 (-12.3%), $25.87 million in FY2022 (-10.0%) and $28.74 million in FY2021.
- The five-year range for quarterly Operating Leases is $14.27 million (Q1 2026) to $29.41 million (Q3 2021).
- Year-over-year, Operating Leases has declined for 16 consecutive quarters, with an average decline of 17.7% over the last eight quarters.
- Across the past five years, year-over-year decline in Operating Leases ran from 9.5% in Q3 2022 to 21.7% in Q1 2026.
- Business Quant data shows DYN's Operating Leases at $14.27 million (Q1 2026), $15.28 million (Q4 2025) and $16.28 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Dyne Therapeutics | 2.59 Bn | -1.18 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.51 Mn |
| Mar 31, 2026 | 14.27 Mn |
| Dec 31, 2025 | 15.28 Mn |
| Sep 30, 2025 | 16.28 Mn |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 18.22 Mn |
| Dec 31, 2024 | 19.14 Mn |
| Sep 30, 2024 | 20.04 Mn |
| Jun 30, 2024 | 20.94 Mn |
| Mar 31, 2024 | 21.86 Mn |
| Dec 31, 2023 | 22.70 Mn |
| Sep 30, 2023 | 23.51 Mn |
| Jun 30, 2023 | 24.32 Mn |
| Mar 31, 2023 | 25.12 Mn |
| Dec 31, 2022 | 25.87 Mn |
| Sep 30, 2022 | 26.61 Mn |
| Jun 30, 2022 | 27.35 Mn |
| Mar 31, 2022 | 28.07 Mn |
| Dec 31, 2021 | 28.74 Mn |
| Sep 30, 2021 | 29.41 Mn |
API Access
Dyne Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=DYN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "DYN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=DYN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();